SCHEMBL18463561

SCHEMBL18463561

CC1(C)c2ccccc2-c2c(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc5c4-c4ccccc4C5(C)C)n3)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 3/20 0.39
ADORA3 P0DMS8 2/20 0.39
ALOX15 P16050 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA2B P29275 2/20 0.39
ADORA1 P30542 2/20 0.39
PDK2 Q15119 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
LMNA P02545 2/20 0.35
KDM4E B2RXH2 2/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 2/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
ADK P55263 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18463295 1.00 L3MBTL1 (0.41) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL22059018 1.00 L3MBTL1 (0.41) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL17252444 0.97 L3MBTL1 (0.43) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL22038445 0.94 L3MBTL1 (0.37) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL26937498 0.94 L3MBTL1 (0.37) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL23697394 0.94 L3MBTL1 (0.39) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL17151617 0.94 L3MBTL1 (0.41) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL17151705 0.94 L3MBTL1 (0.41) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL18878274 0.94 L3MBTL1 (0.41) L3MBTL1TSHRADORA3ALOX15ADORA2A
SCHEMBL23770429 0.93 L3MBTL1 (0.36) L3MBTL1TSHRADORA3ALOX15ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328841-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-10-11 EP disclosed
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
WO-2017016630-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, NES, PIR L3MBTL1 1917/4885TSHR 4263/4885ADORA3 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.